Amgen Stock Plunges Following Disappointing Weight Loss Drug Data
A Big’s Story: Introducing Amgen The biotechnology world buzzed with anticipation, whispers of groundbreaking remedies and potential monetary windfalls swirling within the air. On the coronary heart of this pleasure stood Amgen, a titan of the trade recognized for its pioneering spirit and relentless pursuit of modern medicines. Nonetheless, the latest launch of scientific trial … Read more
